Article

Value of Whole‐Body Washing With Chlorhexidine for the Eradication of Methicillin‐Resistant Staphylococcus aureus: A Randomized, Placebo‐Controlled, Double‐Blind Clinical Trial •

Hygiene-Institut, University of Heidelberg, 69 120 Heidelberg, Germany.
Infection Control and Hospital Epidemiology (Impact Factor: 3.94). 10/2007; 28(9):1036-43. DOI: 10.1086/519929
Source: PubMed

ABSTRACT Whole-body washing with antiseptic solution has been widely used as part of eradication treatment for colonization with methicillin-resistant Staphylococcus aureus (MRSA), but evidence for the effectiveness of this measure is limited.
To study the efficacy of whole-body washing with chlorhexidine for the control of MRSA.
Randomized, placebo-controlled, double-blinded clinical trial.
University Hospital of Heidelberg and surrounding nursing homes.
MRSA carriers who were not treated concurrently with antibiotics effective against MRSA were eligible for the study.
Five days of whole-body washing with either 4% chlorhexidine solution (treatment group) or with a placebo solution. All patients received mupirocin nasal ointment and chlorhexidine mouth rinse. The outcome was evaluated 3, 4, 5, 9, and 30 days after treatment with swab samples taken from several body sites.
Of 114 patients enrolled in the study (56 in the treatment group and 58 in the placebo group), 11 did not finish treatment (8 from the treatment group and 3 from the placebo group [P=.02]). At baseline, the groups did not differ with regard to age, sex, underlying condition, site of MRSA colonization, or history of MRSA eradication treatment. Eleven patients were MRSA-free 30 days after treatment (4 from the treatment group and 7 from the placebo group [P=.47]). Only groin-area colonization was significantly better eradicated by the use of chlorhexidine. The best predictor for total eradication was a low number of body sites positive for MRSA. Adverse effects were significantly more frequent in the treatment group than in the placebo group (any symptom, 71% vs 33%) but were reversible in most cases.
Whole-body washing can reduce skin colonization, but it appears necessary to extend eradication measures to the gastrointestinal tract, wounds, and/or other colonized body sites if complete eradication is the goal.

2 Followers
 · 
172 Views
  • Source
    • "Liquid antibacterial soap dispensers previously not present now have been installed in dormitories. Chlorhexidine-based liquid soap is now dispensed to inmates with any signs of skin or known MRSA infection (Jarvis, Wynne, Enwright, & Williams, 1979; Suller & Russell, 1999; Wendt et al., 2007). Additional interventions were implemented in accordance with the Federal Bureau of Prisons Clinical Practice Guidelines (Federal Bureau of Prisons, 2005): Inmates are encouraged to shower twice daily. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This article describes a community-based intervention to manage an outbreak of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections in a midwestern county jail. A systematic investigation conducted by a family medicine residency program identified 64 total cases and 19 MRSA cases between January 1 and December 31, 2007. Factors contributing to MRSA transmission included inadequate surveillance, lack of antibacterial soap, and a defective laundry process. All 19 isolates were CA-MRSA and all seven tested by pulsed-field gel electrophoresis (PFGE) were USA300. Four of the seven isolates showed variation of their PFGE patterns. A primary care approach using community-based resources effectively reduced the number of cases in this heterogeneous outbreak of CA-MRSA, with the last MRSA being isolated in October 2007.
    Journal of Correctional Health Care 07/2010; 16(3):205-15. DOI:10.1177/1078345810366679
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dans de nombreux pays d’Europe et aux États-Unis, 5 à 15 % des patients sont porteurs de Staphylococcus aureus résistant à la méticilline (SARM) à l’admission en réanimation, bien qu’un déclin dans les taux d’isolement hospitaliers ait été observé dans certains pays depuis dix ans. La colonisation à SARM comporte un risque majeur d’infection acquise ultérieure. La décolonisation pour éradiquer le portage a été proposée de longue date dans la prévention des infections à SARM liées aux soins. Parmi les médicaments utilisés, un antibiotique topique, la mupirocine, a été largement étudié et permet la décolonisation nasale. Son efficacité sur le SARM est limitée du fait de la persistance du portage sur d’autres sites. Certains antibiotiques systémiques ont été proposés (rifampicine, doxycycline) pour éradiquer le portage. La toilette cutanée à la chlorhexidine gluconate à 4 % est également largement utilisée, notamment en association avec la mupirocine nasale. L’intérêt de la décolonisation reste très controversé. Elle fait partie intégrante des mesures de prévention recommandées dans quelques pays européens. D’autres experts préconisent seulement le dépistage des porteurs, le renforcement des mesures d’hygiène standard et les mesures d’isolement des patients colonisés ou infectés. La disparition de certains clones endémiques a contribué à modifier l’épidémiologie, indépendamment des mesures de prévention prises. Enfin, les rôles respectifs de la contamination de l’environnement et du portage chez le personnel soignant ont été fréquemment sous-estimés. De plus, l’apparition de souches de SARM résistantes a été associée à l’utilisation courante de la mupirocine. Il n’existe pas de recommandations universelles mais plutôt des protocoles institutionnels variables selon l’épidémiologie locale.
    Réanimation 05/2013; 22(3). DOI:10.1007/s13546-013-0671-1
Show more